Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABT

MedTech’s bright future is fueled by rapid tech advancements and increasing demand for medical devices, implants, and precision treatments, driven by an aging population and rising global disease rates. Given this backdrop, adding strong MedTech stocks like Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) to one’s portfolio could be…

StockNews.com

3 Dividend Kings With Massive Dividend Growth Rates

Learn how these three dividend kings can boost your portfolio's income potential.

Barchart

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott has lagged the broader market over the past year, but analysts are optimistic about the stock’s prospects.

Barchart

Neo-Nazi Gang Affiliates Attacked a Mixed-Race Family in Martindale, Only One Was Arrested

Members or supporters of the Aryan Brotherhood of Texas, identified by the Texas Observer and Bellingcat, appear to have perpetrated a possible hate crime at the location of a river tubing company.

Texas Observer

Di Grassi commits to Abt and Lola Formula E project

The Abt Formula E team has confirmed that Lucas di Grassi will stay with the squad for next season when it will use the Lola/Yamaha powertrain for the first time.

Autosport

Muller left Abt Formula E team for "new challenge", poised to join Andretti

Nico Muller says that his decision to leave the Abt Formula E team was fuelled by the need for a “new challenge” as he looks poised to join Andretti.

Motorsport

Read news from The Economist, FT, and more,
with one subscription

Abbott's Q2 2024 Earnings: What to Expect

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

Barchart

3 Healthcare Stocks Set to Benefit From Aging Population Trends

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

StockNews.com

At 61, ballerina Alessandra Ferri is giving her pointe shoes one last — maybe? — glorious whirl

When Alessandra Ferri, one of the world's most celebrated dramatic ballerinas, takes the stage Friday at the Metropolitan Opera House to channel Virginia Woolf, logic dictates it will be her last dance appearance

The Independent UK

Carlos López: Latino pride and "Like Water for Chocolate" at the American Ballet Theatre in New York City - Interview

Carlos López: Latino pride and "Like Water for Chocolate" at the American Ballet Theatre—Interview

Latin Times

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

StockNews.com

How Is Abbott's Stock Performance Compared to Other Medical Devices Stocks?

Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

Barchart

Lola commits to Formula E Gen4, Yamaha undecided

The iconic British brand announced in March that it would return to motorsport for the first time in more than a decade as a powertrain supplier in the all-electric championship, starting with the 2024-25 season.

Motorsport

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Abbott Stock: Analyst Estimates & Ratings

Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.

Autosport

Audi squad perplexed that Preining escaped with Lausitzring DTM warning

Van der Linde had moved into the lead of Sunday’s DTM race thanks to a brilliant overcut strategy executed by Abt Sportsline, jumping both team-mate Ricardo Feller and Manthey EMA driver Preining.

Motorsport

DTM Lausitzring: Preining outsmarts Audi duo to take Sunday win

Manthey EMA’s Preining fell behind both van de Linde and Feller at one stage, but quickly repassed the Abt Audi duo to claim his first win of the 2024 season and move up to second in the standings.

Dynamite News

Two suspected Bangladeshi terrorists arrested in Assam

Two suspected Bangladeshi terrorists belonging to the Ansarullah Bangla Team (ABT) were arrested in Guwahati, police said. Read further on Dynamite News:

Get all your
news in one place.

100's of premium titles.
One news app.

Autosport

Rast fastest as BMW dominates Hockenheim DTM test

Three-time DTM champion Rast set a best time of 1m37.077s on the second and final day of the running at Hockenheim to top the timesheets ahead of Schubert Motorsport team-mates Sheldon van der Linde and Marco Wittmann.

Motorsport

Abt to be powered by Lola/Yamaha's Formula E powertrain

The long-expected confirmation comes only weeks after it was revealed ahead of the Tokyo E-Prix that Lola Cars would be returning to motorsport after more than a decade away, while Yamaha would be venturing into four-wheel racing again for the first time since 1997.

Autosport

The significance of Lola and Yamaha’s Formula E project

Motorsport fans of a certain age will need no reminder about how both Lola and Yamaha endured generally torrid Formula 1 campaigns 27 years ago, the last for each in the category. The former botched its attempt to make the grade after both of its drivers comprehensively failed to qualify…

Top News

Abbott Laboratories Reports Strong Earnings Despite Recent Challenges

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

StockNews.com

Analyzing 2024 Gain Potential in 3 Medical Stocks

The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on….

Motorsport

Di Grassi "100%" trusts Abt decision to end Mahindra Formula E partnership

During the Mexico City E-Prix race meeting, it was revealed that Abt had terminated its contract with Mahindra on the eve of the season-opener, with the collaboration set to finish at the end of 2024.

Autosport

Di Grassi trusts "100%" Abt decision to end Mahindra Formula E partnership

During the Mexico City E-Prix race meeting it was revealed that Abt had terminated its contract with Mahindra on the eve of the season-opener, with the collaboration set to finish at the end of 2024.

1 … 4 5 6 7

People

Sheldon van der Linde

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.